PMID: 9640489Jun 26, 1998Paper

Selective serotonin-reuptake inhibitor-induced movement disorders

The Annals of Pharmacotherapy
P E Gerber, L D Lynd

Abstract

To compile and evaluate all available data suggesting an association between selective serotonin-reuptake inhibitor (SSRI) administration and the occurrence of movement disorders, and to characterize these reactions in terms of onset, duration, treatment and outcome, and potential predisposing factors. Reports of movement disorders were identified by conducting a comprehensive literature search that included tertiary adverse drug reaction resources, MEDLINE, EmBASE, Biological Abstracts, Current Contents, Reactions, ClinAlert, and International Pharmaceutical Abstracts. In addition, reports were solicited from the Canadian proprietary manufacturers of SSRIs, and from the Therapeutic Products Program of Health Canada. Each case was then classified according to the description of the movement disorder, based on predefined diagnostic criteria. A total of 127 published reports of SSRI-induced movement disorders were identified involving akathisia (n = 30), dystonia (19), dyskinesia (12), tardive dyskinesia (6), parkinsonism (25), and 15 cases of mixed disorders. Ten isolated cases of bruxism were identified. Ten additional reports could not be classified. Manufacturers of SSRIs provided 49 reports of akathisia, 44 of dystonia, 208 ...Continue Reading

References

Jan 1, 1992·Movement Disorders : Official Journal of the Movement Disorder Society·C E ClarkeA House
Apr 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·V Wils
Oct 1, 1991·The American Journal of Psychiatry·C L Budman, R D Bruun
Jan 1, 1991·International Clinical Psychopharmacology·D BaldwinS Montgomery
Nov 1, 1991·The American Journal of Psychiatry·H B GernaatD J Touw
May 1, 1991·The American Journal of Psychiatry·M H Stein
Oct 1, 1989·The American Journal of Psychiatry
Mar 1, 1989·The American Journal of Psychiatry·J L Tate
Sep 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·A al-Adwani
Jun 1, 1995·International Clinical Psychopharmacology·M PoyurovskyA Weizman
Mar 1, 1995·Biological Psychiatry·L A Adler, B M Angrist
Feb 1, 1995·The American Journal of Psychiatry·R K SinghB Singh
Jun 1, 1994·The Australian and New Zealand Journal of Psychiatry·A ManderN Christophidis
Apr 1, 1994·The American Journal of Psychiatry·L A Opler
Oct 1, 1993·Journal of Clinical Psychopharmacology·D W Oslin, K Duffy
Oct 1, 1993·Journal of Clinical Psychopharmacology·D K Arya, E Szabadi
Jan 1, 1994·The American Journal of Psychiatry·M Dave
Jun 1, 1993·Journal of Clinical Psychopharmacology·L D LaPorta
Sep 1, 1995·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·S A Chong
Oct 1, 1995·Journal of Geriatric Psychiatry and Neurology·R J LeoL A Hershey
Nov 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·V Murray
Dec 1, 1995·The Annals of Pharmacotherapy·A L Lazowick, G M Levin
May 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·K J Bharucha, K D Sethi
Jun 1, 1996·Journal of Clinical Psychopharmacology·S D Botsaris, J M Sypek
Aug 1, 1996·Journal of Clinical Psychopharmacology·T G Lesaca
Aug 1, 1996·Journal of Clinical Psychopharmacology·S A Chong, C H Tan
Sep 1, 1996·Psychiatric Services : a Journal of the American Psychiatric Association·S L Dubovsky, M Thomas
Oct 1, 1996·The Journal of Clinical Psychiatry·R J Leo
Jan 1, 1996·European Psychiatry : the Journal of the Association of European Psychiatrists·P ThomasM Goudemand

❮ Previous
Next ❯

Citations

Jul 1, 2011·Pain Management·Joel J Napeñas, Joanna M Zakrzewska
Aug 23, 2006·Clinical Oral Investigations·Gustavo Hauber GameiroMaria Cecília Ferraz de Arruda Veiga
Jul 23, 2014·Psychopharmacology·Jagtar Singh Nimber, Ashish Aggarwal
Oct 1, 2012·Acta Neuropsychiatrica·Deshandra M Raidoo
Sep 30, 2006·American Journal of Public Health·Robert E McKeownRichard M Schulz
Apr 15, 2009·Journal of Child and Adolescent Psychopharmacology·Shauna P ReinblattMark A Riddle
Jun 1, 2006·Neuropsychiatric Disease and Treatment·Ranita Basu, Jaspreet S Brar
Sep 22, 2011·Brain : a Journal of Neurology·Maria StamelouKailash P Bhatia
Sep 6, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Oliver PogarellKlaus Tatsch
Jun 1, 2006·Current Psychiatry Reports·Matthew MenzaHumberto Marin
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Meera VaswaniSubramanyam Ramesh
Dec 7, 2005·Journal of Neurology·Liborio RampelloFrancesco Nicoletti
Jan 4, 2007·European Journal of Clinical Pharmacology·Maurits E L ArbouwToine C G Egberts
May 15, 2004·Journal of Child and Adolescent Psychopharmacology·Kenneth N SokolskiEdward M Demet
Mar 18, 2009·Journal of the American Pharmacists Association : JAPhA·Lindsey P Koliscak, Eugene H Makela
Jul 23, 2003·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Rasih Atilla EnerRollin M Gallagher
Apr 7, 2012·Dental Clinics of North America·Maria Clotilde CarraGilles Lavigne
Jun 28, 2011·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·F Martínez-GranadosM A Bernabéu Martínez
Oct 28, 2014·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Mar 18, 2008·Oral and Maxillofacial Surgery Clinics of North America·Ramesh Balasubramaniam, Saravanan Ram
Dec 23, 2006·Dental Clinics of North America·Glenn T Clark, Saravanan Ram
Aug 10, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Stéphane ThoboisEmmanuel Broussolle
Jun 21, 2007·British Journal of Clinical Pharmacology·James C Milton, Aza Abdulla
May 8, 2009·The European Journal of Neuroscience·Craig P Blomeley, Enrico Bracci
Apr 22, 2009·Journal of Oral Rehabilitation·K E ByrdT M Talavage
Mar 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Yevgeniy KuznetsovYvan Boulanger
Jul 28, 2012·Psychiatry and Clinical Neurosciences·Panagiotis OulisKonstantinos Kollias
Feb 19, 2010·Fundamental & Clinical Pharmacology·David DevosR Bordet
Dec 24, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Fedra Najjar, Lawrence H Price
Jul 13, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Keith Da Silva, Louis Mandel
Feb 21, 2006·Physiology & Behavior·Gustavo Hauber GameiroMaria Cecília Ferraz de Arruda Veiga
Dec 20, 2005·La Revue de médecine interne·J ArzurA Coquerel
Feb 11, 2015·Psychosomatics·Robert Joseph Morgan, Tamara J Dolenc
Nov 8, 2014·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Agnieszka Dyduch, Maria Załuska
Mar 16, 2001·Expert Opinion on Pharmacotherapy·S Mace, D Taylor
Mar 12, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Samantha J PodurgielJohn D Salamone
Nov 26, 1999·The Journal of the American Dental Association·E S Brown, S C Hong
Oct 2, 2012·The Journal of the American Dental Association·Seena B Patel, Satish K S Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
M R Lemke
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
E Erdem, A Alkan
© 2022 Meta ULC. All rights reserved